Want to join the conversation?
$HALO 2Q15 Call: We are moving forward with our plans for our Phase 3 study in previously untreated metastatic pancreatic cancer patients following the key end of Phase 2 meeting with FDA and now following scientific advice from EMA. We will complete enrollment of PEGPH20 study 202 by end of 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?